Modernizing a U.S. Biotechnology Firm for Compliance and Growth
Bonelli Systems
&
Life-Science Innovations
A U.S. biotech company managing highly sensitive data faced serious operational and regulatory challenges due to over 20 years of legacy systems and fragmented identity data. Bonelli Systems modernized the company’s digital foundation by automating the cleanup of legacy records, rebuilding the identity infrastructure on a secure cloud platform, and implementing a security and data governance strategy aligned with HIPAA and FDA standards. This transformation improved operational clarity, enabled a flexible and secure hybrid workforce, and built a stronger foundation for regulatory compliance and future AI innovation.
Challenge
Life-Science Innovations was weighed down by 20+ years of outdated systems, fragmented identity data, and weak security controls. These legacy gaps put sensitive biotech research and regulatory compliance at risk, slowed innovation, and made it difficult to support a modern, hybrid workforce. Without visibility, governance, and a secure digital foundation, the company faced rising risk, inefficiency, and limited agility.
Solution
Bonelli Systems modernized LSI’s digital foundation by:
- Cleaning 20+ years of identity records to restore data accuracy and cut risk.
- Rebuilding identity infrastructure with Entra Active Directory for centralized control and compliance readiness.
- Securing devices, users, and data with modern, scalable protections aligned to HIPAA/FDA standards.
- Deploying Windows 365 & data governance tools to enable secure hybrid work, streamline audits, and lay the groundwork for AI-driven innovation.
Service Focus
- Migration Modernization – Cleaned up 20+ years of identity data and rebuilt core systems on a secure, scalable cloud foundation, enabling hybrid work and operational clarity.
- Security & Compliance – Implemented end-to-end protections aligned with HIPAA/FDA standards, securing sensitive biotech research and strengthening regulatory readiness.
- AI & Data Governance – Established clear ownership and protection of sensitive data, streamlining audits and laying a trusted foundation for AI-driven innovation.
✓ Migration & Workforce Enablement
Cleared 20+ years of inconsistent identity records, improving operational clarity and cutting IT overhead.
Enabled a more agile and productive workforce with secure, cloud-based desktops and hybrid work support.
✓ Security & Compliance
Gained clear control over sensitive research, partner, and employee data.
Locked down research data, strengthened legal and compliance readiness, and met HIPAA/FDA standards—reducing regulatory risk.
✓ AI, Analytics & Data Innovation
Gained total data visibility to speed up audits and improve decision-making.
Built a reliable foundation for AI-driven innovation and future data initiatives.
Life-Science Innovations was stuck with 20+ years of legacy systems, compliance risks, and inefficiencies slowing down discovery. Bonelli Systems modernized their digital backbone—cleaning identity data, centralizing control with Entra Active Directory, and enabling hybrid work with Windows 365.
Security gaps were closed with real-time monitoring and FDA/HIPAA-aligned safeguards, while a new data governance strategy protected sensitive research and set the stage for AI-driven breakthroughs.
The Result: A secure, compliant, and agile biotech leader—ready to scale, attract top talent, and accelerate innovation.
Immediate Crisis:
Life-Science Innovations was trapped in two decades of outdated systems and fragmented identity data. Sensitive biotech research sat on shaky foundations—exposing the company to compliance gaps, inaccurate user records, and escalating security risks. Without visibility or control, leadership couldn’t safeguard critical data, support a hybrid workforce, or confidently scale operations. In short: innovation was stalled, compliance was threatened, and the business was one breach away from disaster.
Technical Debt:
With over two decades of legacy systems and fragmented identity data, Life-Science Innovations was buried under technical debt. Outdated infrastructure slowed operations, increased compliance risks, and left leadership blind to access issues. Inaccurate user records and siloed systems weren’t just inefficiencies—they were liabilities, preventing the company from scaling, securing sensitive biotech data, and enabling a hybrid workforce.
Business Impact:
Life-Science Innovations was held back by 20+ years of legacy systems, fragmented identity data, and outdated security. This created compliance risks, limited operational visibility, and slowed innovation in a highly regulated biotech sector. Without modern infrastructure, the company struggled to protect sensitive research, enable secure hybrid work, or prepare for AI-driven data insights—putting growth, compliance, and competitive edge at risk.
-
- Modernized Systems: Cleaned up 20+ years of identity data and rebuilt secure infrastructure.
- Enabled Hybrid Work: Deployed Windows 365 for anywhere, anytime productivity.
- Built-In Compliance: Embedded HIPAA/FDA standards into daily operations.
- Future-Proofed Data: Established governance to protect IP and enable AI-driven innovation.
-
- Cleansed & Modernized Identity Data – Automated cleanup of outdated records, eliminating risks from access mismanagement.
- Centralized Control – Deployed Entra Active Directory for secure, scalable governance across users, devices, and policies.
- Enabled Secure Hybrid Work – Rolled out Windows 365 desktops, empowering teams to work from anywhere while protecting sensitive research data.
- Strengthened Security & Compliance – Applied modern safeguards, real-time monitoring, and industry-aligned policies to protect IP, ensure HIPAA/FDA compliance, and build regulator trust.
- Future-Proofed Data for AI – Introduced a governance framework that secures proprietary research, simplifies audits, and creates a reliable foundation for advanced analytics.
- Identity Cleanup: Automated removal of 20+ years of inconsistent records, cutting administrative overhead by 40% and reducing access-related risks by 70%.
- Hybrid Workforce Enablement: Deployed Windows 365, giving employees secure remote access; productivity increased by 25% and IT support tickets dropped by 30%.
- Regulatory Confidence: Achieved HIPAA/FDA compliance readiness, cutting audit preparation time by 50% and avoiding potential fines.
- Stronger Security Posture: Centralized policies reduced endpoint vulnerabilities by 60%, ensuring protection of high-value biotech research.
- Data-Driven Future: Established a governed data foundation, enabling faster audits, fewer errors, and readiness for AI adoption—unlocking an estimated $2M+ in innovation ROI over 3 years.
Cleaning up two decades of legacy identity data before migration eliminated risk and ensured a smooth, disruption-free transition.
Embedding security and compliance standards (HIPAA, FDA) directly into daily operations transformed compliance from a burden into a business enabler.
A governed, transparent data foundation is essential for biotech firms—unlocking AI and analytics safely while protecting proprietary research and IP.
Lessons Learned
1. The Danger of Single-Point-of-Control
Relying on fragmented systems and single points of control left Life-Science Innovations exposed to risk and inefficiency. Centralizing identity, security, and data governance proved that true resilience comes from shared visibility and distributed safeguards—not from one system or person holding all the keys.
2. Proactive Security Architecture is Non-Negotiable
Life-Science Innovations proved that in biotech, waiting to fix security is not an option. Outdated defenses don’t just risk data loss—they threaten regulatory standing, investor trust, and the pace of scientific breakthroughs. By embedding security and compliance into the foundation of their IT environment, the company didn’t just avoid risk—they gained the confidence to scale, innovate, and protect their most valuable asset: their research.
3. Global Operations Require Global Compliance
For Life-Science Innovations, modernizing technology wasn’t just about efficiency—it was about trust. Sensitive biotech data, international regulations, and hybrid teams demand a foundation where security, governance, and compliance are baked into daily operations. The lesson is clear: global operations succeed only when compliance is treated as a strategic driver, not an afterthought.
